Literature DB >> 16463657

Construction of eukaryotic expression vector of human CC10 gene and expression of CC10 protein in lung adenocarcinoma A549 cell line.

Sheng Zhong1, Yongjian Xu, Zhenxiang Zhang.   

Abstract

A mammalian expression plasmid pcDNA3. 1-hCC10 was constructed and identified, then CC10 protein expression in A549 lung cancer cell line was detected. A 273 bp cDNA fragment was amplified from the total RNA of normal lung tissue by using RT-PCR and cloned into expression plasmid cDNA3. 1, and the recombinant plasmid was identified by employing double digestion restriction enzymes Hind III and BamH I and the cDNA sequence was assayed by the Sanger dideoxy-mediated chain termination method. The segment was then transfected into the A549 lung cancer cell line. The protein expression of CC10 was detected by immunofluorescence and Western blot. Our results showed that the cDNA fragment included the entire coding region (273 bp). The recombinant eukaryotic cell expression vector of pcDNA3. 1-hCC10 was successfully constructed, and the sequence of the insert was identical to the published sequence. A549 cells line transfected with the pcDNA3. 1-hCC10 expressed high level of CC10 protein. The recombinant plasmid cDNA3. 1-hCC10 may serve as an effective tool for the study of tumorogenesis and tumor treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16463657     DOI: 10.1007/BF02896000

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Overexpression of CC10 modifies neoplastic potential in lung cancer cells.

Authors:  E Szabo; A Goheer; H Witschi; R I Linnoila
Journal:  Cell Growth Differ       Date:  1998-06

2.  Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer.

Authors:  T P Fleming; M A Watson
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 3.  The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression.

Authors:  R I Linnoila; E Szabo; F DeMayo; H Witschi; C Sabourin; A Malkinson
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

4.  Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers.

Authors:  N Shijubo; Y Itoh; T Yamaguchi; Y Shibuya; Y Morita; M Hirasawa; R Okutani; T Kawai; S Abe
Journal:  Eur Respir J       Date:  1997-05       Impact factor: 16.671

5.  Increased susceptibility of mice lacking Clara cell 10-kDa protein to lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen in cigarette smoke.

Authors:  Yongping Yang; Zhongjian Zhang; Anil B Mukherjee; R Ilona Linnoila
Journal:  J Biol Chem       Date:  2004-05-17       Impact factor: 5.157

6.  Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions.

Authors:  A Bernard; H Roels; R Lauwerys; R Witters; C Gielens; A Soumillion; J Van Damme; M De Ley
Journal:  Clin Chim Acta       Date:  1992-05-15       Impact factor: 3.786

Review 7.  Clinical aspects of Clara cell 10-kDa protein/ uteroglobin (secretoglobin 1A1).

Authors:  Noriharu Shijubo; Isao Kawabata; Noriyuki Sato; Yoshihisa Itoh
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

8.  Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines.

Authors:  R A Jesudasan; R A Rahman; S Chandrashekharappa; G A Evans; E S Srivatsan
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

Review 9.  Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer.

Authors:  Steven R Patierno; Michael J Manyak; Patricia M Fernandez; Angela Baker; Ashani T Weeraratna; David S Chou; Greg Szlyk; K Shane Geib; Christopher Walsh; John Patteras
Journal:  Clin Prostate Cancer       Date:  2002-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.